Vericel (VCEL) Preferred Shares (2013 - 2016)
Vericel recorded quarterly Preferred Shares of $38.4 million in Q4 2016, little changed quarter-over-quarter from $38.4 million in Q3 2016, and up 1118.7% year-over-year from $3.2 million in Q1 2016.
Vericel's Preferred Shares history runs 4 years deep, the most recent figure standing at $38.4 million for Q4 2016.
- In Q4 2016, Preferred Shares rose 1118.7% year-over-year to $38.4 million; the TTM figure through Dec 2016 stood at $38.4 million (up 1118.7% YoY), while the FY2016 annual figure was $38.4 million, up 1118.7% from the prior year.
- Preferred Shares came in at $38.4 million for Q4 2016 at Vericel, roughly flat from $38.4 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $38.4 million in Q3 2013 to a low of $3.2 million in Q4 2015.
- A 4-year average of $35.9 million and a median of $38.4 million in 2013 frame the typical range for Preferred Shares.
- Across the five-year window, Preferred Shares sank 91.79% in 2015 and soared 1118.7% in 2016, its largest moves.
- Vericel's Preferred Shares stood at $38.4 million in 2013, then changed by 0.0% to $38.4 million in 2014, then tumbled by 91.79% to $3.2 million in 2015, then jumped by 1118.7% to $38.4 million in 2016.
- According to Business Quant data, Preferred Shares over the past three periods registered $38.4 million, $38.4 million, and $38.4 million for Q4 2016, Q3 2016, and Q2 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 38.39 Mn |
| Sep 30, 2016 | 38.39 Mn |
| Jun 30, 2016 | 38.39 Mn |
| Mar 31, 2016 | 38.39 Mn |
| Dec 31, 2015 | 3.15 Mn |
| Sep 30, 2015 | 38.39 Mn |
| Jun 30, 2015 | 38.39 Mn |
| Mar 31, 2015 | 38.39 Mn |
| Dec 31, 2014 | 38.39 Mn |
| Sep 30, 2014 | 38.39 Mn |
| Jun 30, 2014 | 38.39 Mn |
| Mar 31, 2014 | 38.39 Mn |
| Dec 31, 2013 | 38.39 Mn |
| Sep 30, 2013 | 38.39 Mn |